Removing Race Adjustment in Chronic Kidney Disease Care
A new study led by Stanford Health Policy researchers finds that algorithmic changes to a chronic kidney disease care equation are likely insufficient to achieve health equity as many other structural inequities remain.
QALY Ban Could Harm People with Disabilities and Chronic Illness
The U.S. House passed a bill that would ban the use of a metric known as quality-adjusted life-years (QALYs) in coverage and payment determinations for federal health-care programs. SHP's Joshua Salomon writes in this Health Affairs commentary the bill would compromise the evaluation of medical treatments.
In Conflict Zones and Borderlands, Paul Wise Protects the Health of Vulnerable Children
Stanford Health Policy's Paul Wise — professor of pediatrics and senior fellow at the Freeman Spogli Institute for International Studies — is featured in this Stanford Magazine story about his work at the U.S.-Mexico border as the federally appointed juvenile monitor and around the world as a pediatrician who works on behalf of children of conflict.
Stanford’s Center for Open and Reproducible Science aims to make science – and research in general – more effective and accessible. “Stanford is absolutely the right place to have a center like CORES because we have such a strong tradition of data science," says SHP's Michelle Mello, a member of the CORES executive committee.
Michelle Mello evaluates the benefits and challenges of California's novel health equity focus in its reopening efforts and outlines recommendations for other U.S. states to address disparities in their reopening plans.
Now that a third COVID-19 vaccine has been given emergency-use authorization, Michelle Mello and colleagues ask whether individuals should be able to choose which vaccine they receive.
Stanford Law School health law experts Michelle Mello and David Studdert, also professors of medicine at Stanford Health Policy, share insights into the government’s response and offer hope that science —and unbiased scholarly research — can help curtail the rising toll of COVID-19.
The urgency of the coronavirus pandemic has led to enormous research efforts and some shortcuts. Michelle Mello, a professor of medicine and law, and David Magnus, a professor of medicine and biomedical ethnics, write in this Scientific American commentary that the scientific surge to understand COVID-19 is inspiring — but has led to some ethical dilemmas.
SHP's Jeremy Goldhaber-Fiebert, David Studdert and Michelle Mello write in this JAMA Health Forum Insight that school reopening efforts must account for characteristics of the communities within which schools are embedded.
Stanford Health Policy's Michelle Mello and Stanford medical student Yasmin Rafiei write in this New England Journal of Medicine perspective that most school reopening plans focus on screening for Covid-19 symptoms. Yet recent research indicates that symptom screening alone will not enable schools to contain Covid-19 outbreaks.
SHP's Michelle Mello writes in this commentary in JAMA Network that the attacks on and harassment of public health officials for taking steps to protect their communities from COVID-19 is extraordinary in its scope and nature, use of social media — and poses a danger to the ongoing pandemic response.
Many jurisdictions have responded to the unevenness of the COVID-19 pandemic by battening down their borders. SHP's David Studdert and Michelle Mello take a deep dive into the legalities of attempting to prevent people from crossing state lines in this New England Journal of Medicine perspective.
SHP's Michelle Mello and colleagues note in this New England Journal of Medicine perspective that even when we have a clinically safe and successful vaccine against SARS-CoV-2 — only half of Americans plan to get vaccinated. Should the vaccine be mandated?
Michelle Mello, a professor of medicine and law, examines the reasons behind California's spike in COVID-19 cases and what can be done to bend the curve of the pandemic.
Disabled patients must not be categorically excluded from access to treatment during a pandemic or at any other time of national emergency, writes Stanford Health Policy's Michelle Mello in the New England Journal of Medicine.
On the World Class podcast with Michael McFaul, guests David Relman and Michelle Mello say progress will likely be uneven with states each pursuing varying degrees of social distancing and shelter-in-place policies
